secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0001628280-25-006564
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx reports FY2024 revenue $333.6M; narrows net loss to $39.1M; provides 2025 guidance
--------------------------------------------------------------------------------

- Total revenue $333.6M in 2024, up from $124.5M in 2023; driven by IBSRELA ($158.3M) and XPHOZAH ($160.9M) sales.
- Net loss narrowed to $39.1M ($0.17 per share) from $66.1M ($0.30 per share) in 2023.
- Cash and investments ended at $250.1M; drew $49.7M under term loan in Q4 2024.
- IBSRELA 2025 net sales guidance: $240–250M; reaffirmed peak combined sales potential of $1.75B.
- SG&A expenses rose to $258.7M from $134.4M due to sales team expansion and XPHOZAH launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025006564/0001628280-25-006564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828025006564/ardx-20250220.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-006564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer